Acute myeloid leukemia is a hematologic malignancy with significant molecular
heterogeneity. MicroRNAs have important biological functions and play critical roles in …

Acute myeloid leukemia (AML) is a hematologic malignancy with significant molecular
heterogeneity. MicroRNAs (miRNAs) play a critical role in AML diagnosis, pathogenesis …

Accurately predicting patient outcomes is essential for optimizing treatment and improving
outcomes in pediatric acute myeloid leukemia (AML). In recent years, microRNAs have …

Background MiRNAs that are potential biomarkers for predicting prognosis for acute myeloid
leukemia (AML) have been identified. However, comprehensive analyses investigating the …

Purpose Children with acute myeloid leukemia (AML) whose disease is refractory to
standard induction chemotherapy therapy or who experience relapse after initial response …

Background Recent reports have indicated that microRNAs (miRNAs) play a critical role in
malignancies, and regulations in the progress of adult leukemia. The role of miRNAs in …

As a highly heterogeneous disease, acute myeloid leukemia (AML) needs fine risk
stratification to get an optimal outcome of patients. MicroRNAs have florid biological …

Objectives This study aimed to investigate the risk miRNAs (microRNAs) for AML (acute
myeloid leukemia) prognosis and related regulatory mechanisms. Methods MiRNA and …

BACKGROUND: Acute myeloid leukemia (AML) is characterized by heterogeneity in
phenotypic, genotypic, and clinical traits. miRNAs play an important role in pathogenesis …

Pediatric acute myeloid leukemia (AML) is a heterogeneous disease with respect to biology
as well as outcome. In this study, we investigated whether known biological subgroups of …